Auron will present data highlighting the activity of AUTX-703, its oral, potent and selective degrader targeting KAT2A/B in cell lines and patient derived organoid models (PDXO) of neuroendocrine ...
Critics’ picks for entertainment in the week ahead.
These filmmakers wear their inspirations on their sleeves, yet they have been given the freedom to define their art on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback